Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

Schnitzler syndrome News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A case report highlights the successful use of anakinra to treat SARS-CoV-2 induced Schnitzler syndrome during pregnancy. This study contributes to understanding the inflammatory flare associated with the syndrome in the context of COVID-19.

A multicenter study from the AIDA Network Schnitzler Registry evaluates IL-1 targeting agents in patients with Schnitzler syndrome. The findings contribute to understanding treatment efficacy in this rare disease.

Not rare diseases news,news about your rare disease.

Earlier

A case report highlights the successful use of anakinra to treat SARS-CoV-2 induced Schnitzler syndrome during pregnancy. This study contributes to understanding the inflammatory flare associated with the syndrome in the context of COVID-19.

A multicenter study from the AIDA Network Schnitzler Registry evaluates IL-1 targeting agents in patients with Schnitzler syndrome. The findings contribute to understanding treatment efficacy in this rare disease.

Not rare diseases news,
news about your rare disease.